AstraZeneca has teamed up with Oracle to examine how AI and real-world data can be used to find potential participants for ...
Nine biopharma and biotech companies named new chief financial officers this fall, strengthening finance leadership more ...
Accounting leaders from Biogen, Vertex, Akebia and Roivant share how AI boosts efficiency while human review remains ...
New York-based Pathos AI has secured $237 million in Series E financing at a post-money valuation of approximately $3 billion ...
In the wake of rejection by the Guinea-Bissau Ministry of Public Health, Frederik Schaltz-Buchholzer – one of the study’s ...
Rising trial amendments drive costly change orders, but AI tools help sponsors spot hidden costs and negotiate better final ...
Gilead Sciences has agreed to acquire an oral IL-23R inhibitor program, led by HCXT-2001, from privately held PepStar ...
Zymeworks entered into a global licensing and collaboration agreement with Roche for ZW209, a trispecific T-cell engager ...
Racura is pursuing one of cancer’s most elusive targets, pairing a distinctive MYC-inhibition approach with a data-first path ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results